Detalhe da pesquisa
1.
Discovery of N-(3-fluorophenyl)-1-[(4-([(3S)-3-methyl-1-piperazinyl]methyl)phenyl)acetyl]-4-piperidinamine (GSK962040), the first small molecule motilin receptor agonist clinical candidate.
J Med Chem
; 52(4): 1180-9, 2009 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-19191554
2.
Discovery of novel biaryl heterocyclic EP1 receptor antagonists.
Bioorg Med Chem Lett
; 16(10): 2666-71, 2006 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16503138